Articles, App Notes, Case Studies, & White Papers

1. New Polymer Overcomes Limits In Sustained Drug Delivery In Ophthalmology 3/29/2023

   Challenges specific to eye physiology complicate the development of new therapies and necessitate innovative drug delivery methods. Biodegradable polymers show promise in addressing these challenges.

2. Biodegradable Polymers For Parenteral Drug Delivery 6/1/2022

   Long-acting, complex drug delivery products, particularly those based on injectable microparticles, nanoparticles, and implants, are among the most attractive parenteral products.

3. Transitioning From A Vial To PFS Or Cartridge In An Auto-Injector Device 12/2/2022

   Explore how to approach the transition of migrating from a vial to a syringe or cartridge, the necessary compatibility testing, and the stresses on the bulk product during formulation and filling.

4. 5 Novel Techniques For Solubility Enhancement 2/28/2022

   Thanks to insoluble drug delivery technologies, the practice of reformulating poorly soluble drug products to improve efficacy, patient compliance and safety has now been widely adopted.

5. Key Offerings To Help Support Your OSD On Its Journey To Market

   Examine several important factors needed to effectively support oral solid dosage therapeutic manufacturing and overcome the complexities involved.

6. Is The Autoinjector Dead? The Future Of Patient-Centered Drug Delivery 9/1/2025

   Autoinjectors revolutionized drug delivery, but innovation is shifting toward oral, wearable, and alternative platforms. Future focus emphasizes patient experience, sustainability, and broader drug delivery toolkits beyond the autoinjector.

7. 3D Screen Printing: Enabling A New Generation Of Complex Formulations 3/17/2025

   Screen-Printed Innovative Drug Technology can produce oral, transdermal, and implantable dosage forms while ensuring heterogeneous distribution of active ingredients.

8. Overcoming Melt Processing Challenges 7/21/2023

   Discover how a biodegradable polymer platform, easily applied with hot melt processing, enables processing at a relatively low temperature while preserving the potency of temperature-sensitive APIs.

9. Delivering Macromolecules: Challenges Associated With The Delivery Of Biologic Drugs

   Developers need to look beyond the formulation of a stable drug all the way to patient compliance. Numerous pitfalls exist along the journey to bring a biologic combination product to market. This integrated solutions program can help you simplify the journey.

10. Effects Of Annex 1 Revisions On Manufacturing Operations 12/1/2022

    The revisions to EU Annex 1 set the stage for the future direction of the pharma/biotech industry. Explore some of the key takeaways and interesting changes for risk management and contamination control strategies.